Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-19 11:34 am Purchase |
2022-12-30 | 13G | Sweetgreen, Inc. SG |
BAILLIE GIFFORD & CO | 5,291,714 5.440% |
5,291,714 (New Position) |
Filing History |
| 2023-01-19 11:25 am Sale |
2022-12-30 | 13G | Moderna, Inc. MRNA |
BAILLIE GIFFORD & CO | 44,786,746 11.660% |
-985,333 (-2.15%) |
Filing History |
| 2023-01-18 10:17 am Sale |
2022-12-30 | 13G | Certara, Inc. CERT |
BAILLIE GIFFORD & CO | 10,223,809 6.400% |
-2,321,259 (-18.50%) |
Filing History |
| 2023-01-18 10:03 am Sale |
2022-12-30 | 13G | Cellectis S.A. CLLS |
BAILLIE GIFFORD & CO | 3,149,420 6.910% |
-1,186,463 (-27.36%) |
Filing History |
| 2023-01-18 09:43 am Purchase |
2022-12-30 | 13G | Carvana Co. CVNA |
BAILLIE GIFFORD & CO | 14,168,781 13.370% |
4,512,926 (+46.74%) |
Filing History |
| 2023-01-18 09:38 am Purchase |
2022-12-30 | 13G | Atlassian Corporation TEAM |
BAILLIE GIFFORD & CO | 7,643,211 5.150% |
1,170,104 (+18.08%) |
Filing History |
| 2023-01-18 07:21 am Purchase |
2022-12-30 | 13G | Abcam plc ABCM |
BAILLIE GIFFORD & CO | 12,163,749 5.310% |
12,163,749 (New Position) |
Filing History |
| 2023-01-18 07:06 am Sale |
2022-12-30 | 13G | Copa Holdings, S.A. CPA |
BAILLIE GIFFORD & CO | 4,623,324 14.920% |
-117,217 (-2.47%) |
Filing History |
| 2023-01-18 06:59 am Sale |
2022-12-30 | 13G | Codexis, Inc. CDXS |
BAILLIE GIFFORD & CO | 6,210,551 9.460% |
-971,851 (-13.53%) |
Filing History |
| 2023-01-18 06:56 am Sale |
2022-12-30 | 13G | Cloudflare, Inc. NET |
BAILLIE GIFFORD & CO | 26,335,438 9.250% |
-2,037,525 (-7.18%) |
Filing History |
| 2023-01-18 06:53 am Purchase |
2022-12-30 | 13G | Chewy, Inc. CHWY |
BAILLIE GIFFORD & CO | 17,080,994 15.230% |
3,778,327 (+28.40%) |
Filing History |
| 2023-01-18 06:45 am Sale |
2022-12-30 | 13G | Chegg, Inc. CHGG |
BAILLIE GIFFORD & CO | 17,929,525 14.290% |
-1,079,482 (-5.68%) |
Filing History |
| 2023-01-18 06:41 am Purchase |
2022-12-30 | 13G | Adaptimmune Therapeutics plc ADAP |
BAILLIE GIFFORD & CO | 103,019,634 10.480% |
401,082 (+0.39%) |
Filing History |
| 2023-01-18 06:35 am Purchase |
2022-12-30 | 13G | AbCellera Biologics Inc. ABCL |
BAILLIE GIFFORD & CO | 19,696,735 6.880% |
19,696,735 (New Position) |
Filing History |
| 2023-01-18 06:24 am Purchase |
2022-12-30 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 8,602,235 9.000% |
1,723,858 (+25.06%) |
Filing History |
| 2023-01-06 06:44 am Sale |
2022-12-30 | 13G | Appian Corporation APPN |
BAILLIE GIFFORD & CO | 1,567,182 3.820% |
-2,461,737 (-61.10%) |
Filing History |
| 2023-01-06 06:39 am Sale |
2022-12-30 | 13G | Abiomed, Inc. ABMD |
BAILLIE GIFFORD & CO | 2,991 0.010% |
-3,836,989 (-99.92%) |
Filing History |
| 2022-12-02 07:33 am Purchase |
2022-11-30 | 13G | Adaptimmune Therapeutics plc ADAP |
BAILLIE GIFFORD & CO | 102,618,552 10.440% |
20,080,440 (+24.33%) |
Filing History |
| 2022-12-01 10:35 am Sale |
2022-11-30 | 13G | Appian Corporation APPN |
BAILLIE GIFFORD & CO | 4,028,919 9.810% |
-2,139,977 (-34.69%) |
Filing History |
| 2022-12-01 10:27 am Sale |
2022-11-30 | 13G | Oscar Health, Inc. OSCR |
BAILLIE GIFFORD & CO | 5,430,811 3.020% |
-7,027,072 (-56.41%) |
Filing History |